STATE STREET CORP - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is and the CUSIP is 87164U409. A total of 19 filers reported holding SYNTHETIC BIOLOGICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q3 2023$26,259
-46.1%
48,6910.0%0.00%
Q2 2023$48,691
+43.2%
48,6910.0%0.00%
Q1 2023$34,006
-23.2%
48,691
-50.0%
0.00%
Q4 2022$44,290
-7.7%
97,382
+100.0%
0.00%
Q3 2022$48,00048,6910.00%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 28,528$28,0000.00%
TWO SIGMA SECURITIES, LLC 18,352$18,0000.00%
Virtu Financial LLC 12,447$12,0000.00%
Renaissance Technologies 31,710$31,0000.00%
ROYAL BANK OF CANADA 7$00.00%
VANGUARD GROUP INC 525,085$518,0000.00%
Focused Wealth Management, Inc 50$00.00%
UBS Group AG 6,766$7,0000.00%
OSAIC HOLDINGS, INC. 47$00.00%
BANK OF AMERICA CORP /DE/ 6$00.00%
View complete list of SYNTHETIC BIOLOGICS INC shareholders